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immature neural cells and decreases proliferation
in the hippocampal dentate gyrus
Michael J Stuart1,2, Frances Corrigan1 and Bernhard T Baune1,3*Abstract
Background: The process of neurogenesis in which new neurons are generated by proliferation and differentiation
of neural stem/progenitor cells (NSCs/NPCs) has been a topic of intensive recent investigation. Investigations of the
factors which regulate this process have recently begun to include immune factors including immune cells and
cytokines, however the class of immune proteins designated as chemokines have been relatively neglected.
Increasing evidence for novel brain-specific mechanisms of chemokines beyond their classical chemotactic functions
has suggested that they may play a role in the regulation of NSC/NPC biology.
Methods: We have investigated the role of the chemokine receptor CXCR5 (ligand is CXCL13) in the activity of these
cells through neurobiological and behavioural analysis of CXCR5-deficient mice (CXCR5−/−). These investigations
included: immunohistochemistry for the markers Ki67, nestin, doublecortin, and IBA-1, neurosphere assays, and
the baseline behavioural tests: open field test and sucrose preference test.
Results: We observed a significant increase in doublecortin and nestin staining in the hippocampal dentate gyrus
(P = 0.02 and P = 0.0008, respectively) of CXCR5−/− animals as compared to wild-type controls. This was accompanied
by a decrease in Ki67 staining subgranular zone (P = 0.009). Behavioural correlates included a significant increase in
baseline locomotor activity in an open field test (P <0.00018) and a decrease in stress reactivity in that test (P = 0.015).
Deficiency in CXCR5 was not associated with alterations in hippocampal microglial density, microglial activation or
systemic cytokine levels, nor with loss of NSC/NPC populations in the neurosphere assay.
Conclusions: These findings are the first to describe a brain-specific function of CXCR5 under physiological conditions.
CXCR5 reduces maintenance of immature neural cell populations and enhances proliferation of subgranular zone cells
in the hippocampal dentate gyrus, however the mechanism of these effects remains unclear. Further research into the
regulation of NSC/NPC activity should consider investigation of CXCR5 and other chemokines which may be relevant
to the pathophysiology of psychiatric disorders including depression, anxiety and cognitive impairment/dementia.
Keywords: CXCR5, CXCL13, Chemokine, Proliferation, Stem cell, Progenitor cell, Hippocampus, Depression, CognitionBackground
The process of neurogenesis in which new neurons are
generated by proliferation and differentiation of neural
stem/progenitor cells (NSCs/NPCs) has been a topic of
intensive investigation in recent years. This process has
been demonstrated to persist into adulthood in many
species - including humans where it is believed to be* Correspondence: bernhard.baune@adelaide.edu.au
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stated.localised to several discrete anatomical regions including
the subventricular zone (SVZ) and subgranular zone
(SGZ) of the hippocampal dentate gyrus [1]. The latter
region is of particular interest to the study of human
health and disease given its key functions in learning and
memory [2]. Indeed, the dysregulation of hippocampal
neurogenesis may be relevant to the pathogenesis of
several disease processes of immense public health
significance including depressive disorders and the
spectrum of mild cognitive impairment to Alzheimer’s
type dementia [3,4]. This process may also be relevanttd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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antidepressant medications including selective serotonin
and/or noradrenaline reuptake inhibitors [5]. An enhanced
understanding of the mechanisms by which NSC/NPC
proliferation and differentiation are regulated may there-
fore provide a basic science platform for further transla-
tional work to provide novel diagnostic and therapeutic
tools for these disorders which are lacking in the field.
The regulation of NSC/NPC activity has been shown
to include a complex interplay of many biological systems
including neurotrophic factors (for example, Brain Derived
Neurotrophic Factor (BDNF)) [6], neurotransmitters (for
example, Noradrenaline (NA)) [7], immune cells (for
example, Th1/Th2/Treg balance) [8,9] and soluble immune
factors (for example, Interferon-γ) [10]. It is notable that
the investigation of soluble immune factors to date has
primarily focused on pro-inflammatory cytokines and
other classes, including chemokines, have been relatively
neglected. Emerging evidence has begun to describe novel
actions of the immune proteins designated as chemokines
in the central nervous system (CNS) beyond their classical
chemotactic functions. These may include regulating the
infiltration and activation states of central and peripheral
immune cells, regulation of neuroendocrine functions,
pre- and post-synaptic modulation of neurotransmitter
systems, and possibly direct neurotransmitter-like effects
[11,12]. Recently the chemokine CX3CL1 has been
demonstrated to be a critical mediator of the beneficial
effects of exercise on hippocampal neurogenesis via
regulation of microglial phenotype, therefore it may
be possible that other chemokines might have direct
or indirect effects on the regulation of neurogenesis
including via microglia [13].
We have chosen to investigate the effects of the
chemokine receptor CXCR5 (receptor for CXCL13)
on hippocampal neurogenesis. In the periphery this
protein is known to play a role in directing the migration
of lymphocytes, particularly B cells [14,15]. Modulation of
the systemic immune response may be relevant to the
regulation of hippocampal neurogenesis, for example in
the context of psychiatric disorders [16,17]. It has also
been shown to be widely expressed in the CNS including
on microglia, astrocytes, mature neurons and NPCs;
however, its mammalian neurobiological significance
under physiological conditions remains unknown [18,19].
Recent work in zebrafish has demonstrated that CXCR5
is expressed on radial glia cells (neural progenitor cells),
and is permissive of proliferation of these cells [20].
Therefore CXCR5 has the potential to influence hip-
pocampal neurogenesis by CNS-specific or systemic im-
mune mechanisms. We aim to investigate the roles of
CXCR5 on the activity of hippocampal NSC/NPCs,
whether any effects on those cells are mediated by al-
terations in systemic or CNS-resident immune factors,and the behavioural correlates of these effects. This will be
the first study to investigate such effects.
Materials and methods
The experimental design utilises a simple subtractive
methodology comparing knockout mice for CXCR5 (de-
signated CXCR5−/−) to wild type (WT) in all experimental
steps.
Animals and ethics
The CXCR5−/− animals and WT controls for the study
were acquired from the Jackson Laboratories (http://
jaxmice.jax.org/strain/006659.html). These animals are
on a C57/BL6J background. They were housed in ap-
proved conditions on a 12-hour light/dark cycle in indi-
vidually ventilated cages with three to five animals to
each cage. Food and water were provided ad libitum.
Handling occurred twice per week when each animal was
weighed and assessed for general health. All care oc-
curred under the oversight of a veterinarian.
Cohorts of 11 male and female (3 male, 8 female, total
n = 11) animals of each genotype were aged to 10 weeks
before commencing behavioural studies and were sacri-
ficed by 11 weeks of age for immunohistochemistry
(5 female, 1 male, total n = 6) and protein analysis (3
female, 2 male, total n = 5). Cohorts of 10 male animals
of each genotype were sacrificed at 6 weeks of age for
tissue use in the neurosphere assay, as at this age adult-
derived hippocampal neurospheres are maximal [21].
All animals were sacrificed by cervical dislocation by a
trained operator.
This study received ethics approval from the University
of Adelaide animal ethics committee.
Neurosphere assay
Primary neurospheres from SVZ and hippocampus were
separately generated according to previously published
protocols [13,22]. In brief: hippocampal or SVZ tissue
was digested by incubation in a mixture containing 0.1%
papain (Worthington Biochemical Corporation) and 0.1%
DNaseI (Roche Australia) in HBSS (Thermo Scientific) for
16 min at 37°C, titurating twice during the incubation
period. Next, the tissue was centrifuged at 750 rpm for
5 min, after which the pellet was resuspended and
washed twice in 2 mL of neurosphere growth medium:
mouse NeuroCult NSC basal medium containing mouse
NeuroCult NSC proliferation supplements (Stem Cell
Technologies), 2 μg/mL heparin, 20 ng/mL purified mouse
epidermal-like growth factor (BD Biosciences) and 10 ng/
mL recombinant bovine fibroblast growth factor02 (Roche).
Cells were plated at a density of two hippocampus or
SVZ per 96-well plate (BD Biosciences) with 200 μL of
neurosphere growth medium per well. For depolarisation
KCl was added to half the primary cultures of each
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cultures were incubated for 7 days and hippocampal
cultures for 10 days in humidified 5% CO2. Neurospheres
were then counted using a standard light microscope with
an eyepiece graticule. Small neurospheres (likely derived
from NPCs) were defined as ≥50 μm diameter and large
neurospheres (likely derived from putative NSCs) were
defined as ≥250 μm diameter [21]. Cultures were not
passaged further. The operator was blinded to the geno-
type for counting.
Immunohistochemistry
At time of sacrifice brain tissue was collected from six
animals (5 females, 1 male) of each genotype (n = 6).
These mice were perfused with a 10 mL of 10% formalin
solution through the left ventricle followed by retrieval
of brain tissue and storage in a 10% formalin solution.
Brains were then embedded in paraffin prior to sectioning,
with a series of nine 5 μm sections collected at 200 μm
intervals throughout the thickness of the hippocampus.
Immunostaining was then conducted using antibodies for
Ki67 (Abcam), doublecortin (Millipore), Nestin (Abcam)s
and IBA-1 (Santa-Cruz). Following de-waxing and dehy-
dration, endogenous peroxidase activity was blocked by
incubation with 0.5% hydrogen peroxide in methanol for
30 min. Slides were then washed in 2 × 3 min in phosphate
buffered saline (PBS) before antigen retrieval retrieved
by heating at close to boiling point for 10 min (TRIS
for doublecortin, citrate for others). Once the slides
had cooled below 40°C they were washed with PBS
before being blocked with 3% normal horse serum in
PBS for 30 min. The appropriate primary antibody was
applied to the slides which were left to incubate over-
night (Ki67 1:2,000, doublecortin 1:8,000, Nestin 1:500,
IBA-1 1:1,000). The next day slides were washed in
2 × 3 min of PBS before the appropriate species of IgG
biotintylated antibody was added for 30 min (Dako).
After a further PBS wash, slides were incubated with
streptavidin peroxidase conjugate for 60 min followed
by another rinse with PBS. The immunocomplex was then
visualised with precipitation of DAB (Sigma D-5637) in
the presence of hydrogen peroxide. Slides were washed
to remove excess DAB and lightly counterstained with
haematoxylin, dehydrated and mounted with DePeX
from histolene.
Slides were subsequently digitally scanned using the
Hamamatsu NanoZoomer and examined using the asso-
ciated NDP.view2 software (Hamamatsu). Sequential
images were captured of the hippocampus and exported
for cell counting within Image J 1.46 (NIH) where the grid
and manual cell counter features were utilised. In all
instances the hippocampus or dentate gyrus were counted
in their entirety, bilaterally. Area of each region was
measured in NDP.view2 and results were expressed ascellularity in cells per mm2. The operator was blinded to
the genotype of the slides during the slide analysis process.
Cytometric bead assay
At time of sacrifice blood was collected from five animals
of each genotype (3 females, 2 males) by means of cardiac
puncture and serum was extracted by spinning blood down
at 2,500 rpm for 15 min. Serum was stored at −80°C until
analysis. Serum cytokine levels were measured using the
BD Cytometric Bead Array (CBA) Mouse Inflammation
Kit for the cytokines IL-6, IL-10, MCP-1, IFN-γ, TNF-α
and IL-12p70 according to the manufacturer’s instructions.
Open field test
For the open field and hole-board tests, mice were placed
into the same brightly lit square arena, 40 × 40 cm, with
clear walls 35 cm high. In the open field test, mice were
placed in to the arena for 5 min according to published
protocols [23,24]. The floor was divided into inner and
outer zones. Time spent in each zone was measured as
an indication of anxiety-like behaviour, and total distance
travelled was measured as an indication of baseline loco-
motor activity.
Saccharin preference test
Mice were trained for the saccharin preference test
with a continuous two-bottle choice of water and 0.1%
saccharin for 48 h. For this period, mice were moved to
individual cages which could hold two bottles and the
bottles were switched at 24 h to control for left-right
preference. Immediately after this training period, the
test was conducted. The test involved mice being moved
to individual cages and given the two-bottle choice
of water and 0.1% saccharin for 24 h. This protocol
has been adapted from several previously published
protocols [25,26]. Preference was calculated as: sac-
charin preference % = (saccharin cons./(saccharin cons. +
water cons.)) × 100.
Statistical analysis
All data were analysed using SPSS version 21 software
(IBM). All data passed normality testing using the
Shapiro-Wilk test. Comparisons between genotypes for
all data were made using independent samples T tests.
For all results, a P value of ≤0.05 was considered sig-
nificant. All data presented in graphs are mean values
± standard error of the mean (SEM).
Results
CXCR5 deficiency is permissive of DCX + and Nestin +
population maintenance and suppresses subgranular
zone cell proliferation
We investigated whether CXCR5 deficiency might impact
upon hippocampal neurogenesis in 11-week-old (adult)
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sections for the proliferation marker Ki67, Nestin dou-
blecortin (DCX), markers of immature neuronal cells.
We counted only positive cells within the subgranular
zone for Ki67. Within this subregion Ki67 positive cells
are likely to represent proliferative activity of NPCs, and
Nestin/DCX the immature cells of neuronal lineage which
are generated by the differentiation and migration of
those cells [27]. We found that CXCR5 deficiency was
permissive of increased density of DCX positive cells in
the granular and subgranular zones of the dentage gyrusFigure 1 Effect of CXCR5 deficieny on neurogenesis in the adult dent
significantly reduced compared to WT controls (P = 0.009; n = 6 per group). (B
increased compared to WT controls (P = 0.02; n = 6 per group). (C) In CXCR5−
compared to WT controls (P = 0.0008; n = 6 per group). Representative images(505 ± 19.2 vs. 420 ± 25.9; n = 6 per group; P = 0.02). A
similar trend was observed in nestin positive cells
(331 ± 8.2 vs. 280 ± 7; n = 6 per group; P = 0.0008) (Figure 1).
This implies that CXCR5 signaling may impair the
maintenance of these populations. Additionally, we dem-
onstrated that CXCR5 deficiency suppressed the number
of Ki67 positive cells in the subgranular zone as compared
to WT controls (90.0 ± 6.3 vs. 116.3 ± 5.1; n = 6 per group;
P = 0.009). This may represent indirect suppression of a
compensatory mechanism which would act to maintain
DCX and Nestin positive cells under physiologicalate gyrus. (A) In CXCR5−/− animals the number of Ki67 positive cells was
) In CXCR5−/− animals the number of DCX positive cells was significantly
/− animals the number of Nestin positive cells was significantly increased
of Ki67 (C, D), DCX (E, F) and Nestin (H, I) staining.
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be expressed on NSC/NPC [19]) would support prolifera-
tion of these cells. Taken together these data are most
suggestive that CXCR5 may exert a detrimental effect
on maintenance of Nestin and DCX positive cell popu-
lations - for example through a pro-apoptotic effect - re-
quiring enhanced proliferation of subgranular zone cells
to compensate. A further possibility is that CXCR5 may
support differentiation further down a neuronal lineage,
thereby ‘draining’ the pools of DCX and Nestin positive
cells and requiring an enhancement of subgranular zone
cell proliferation (Ki67 positive) to replace the pool. An
alternative explanation, in which CXCR5 impairs differ-
entiation of proliferating cells into a neuronal lineage is
less likely as this effect would not be expected to simul-
taneously enhance the proliferation of the subgranular
zone precursor/stem cells.
No effect of CXCR5 deficiency on neural stem/progenitor
cell populations
To further interpret the observed in-vivo effects of the
CXCR5 deficiency we also analysed the in-vitro activity
of several subgroups of NPC/NSCs via the neurosphere
culture method. We considered separately the populations
of small (≥50 μm) and large (≥250 μm) hippocampus
derived neurospheres both under basal culture conditions
and the latent populations which are responsive to de-
polarisation with KCl. Previous studies have described
the properties of these populations to include cells of
both NPC and in the case of KCl responsive large spheres
NSC phenotype [21]. In this study we detected no sig-
nificant effects of CXCR5 deficiency on any of these
hippocampal populations in number or size (n = 10 per
group; all P >0.05) (Figure 2). We also detected no signifi-
cant difference in SVZ derived neurospheres (75.5 ± 12.5 vs.
110.9 ± 15.5; n = 10 per group; P = 0.1) (data not shown).Figure 2 CXCR5 deficiency does not alter hippocampus-derived
neural precursor activation. (A) No significant difference in ≥50 μm
neurosphere formation between CXCR5−/− animals and WT controls
under basal culture conditions (P >0.05; n = 10 per group). (B) No
significant difference in ≥50 μm neurosphere formation between
CXCR5−/− animals and WT controls under KCl depolarised conditions
(P >0.05; n = 10 per group).Considered in parallel with the above data, this suggests
that the observed reduction in Ki67 staining seen in
CXCR5−/− animals is not due to an absolute loss of
NPC/NSC populations as these are still reactive to
appropriate in-vitro stimulus. This implies that CXCR5
signalling is not required for maintenance of the prolif-
erative capability of latent NPC/NSC populations.
No effect of CXCR5 deficiency on microglial density,
microglial activation or systemic cytokine levels
To investigate the mechanisms by which CXCR5 deficiency
may produce a deficit in the number of Ki67 positive cells
we investigated several indices of the CNS specific and
systemic immune response which are known to influence
normal neurogenesis. We investigated the density of
IBA-1 positive cells (microglia) in the hippocampus, as
depletion of these cells is known to impair neurogenesis
[13]. We detected no significant effect of CXCR5 defi-
ciency on density of these cells in this study (50.7 ± 3.1 vs.
54.4 ± 2.3 cells/mm2; n = 6 per group; P = 0.37) (Figure 3).
Furthermore, we analysed the percentage of activated
(reactive) microglia on the basis of their classically de-
scribed morphology: large soma, short branches and a
‘bushy’ appearance [28]. We detected no difference in
the percentage of activated microglia (2.25 ± 0.4 vs.
2.52 ± 0.52%; n = 6 per group; P = 0.69) (Figure 3).
We also assayed the levels of systemic cytokines through
use of a cytometric bead assay on serum as several cyto-
kines are known to enhance or impair neurogenesis (for
example, Interferon-γ) [10]. There were no significant
differences between genotypes in serum levels of the
cytokines IFN-γ, IL-6, IL-10, MCP-1, TNF-α or IL-12p70
(all P >0.05) (data not shown). These data suggest
that the observed effects of CXCR5 on Ki67, Nestin
and DCX cell populations are not mediated by alterations
inmicroglial population or gross disruption of soluble
immune factors which may ingress from the systemic
circulation. Under these non-immunologically chal-
lenged experimental conditions, and in the absence of
gross disruption of systemic or glial immune function
we would not anticipate alteration in CNS-specific
cytokine profile.
CXCR5 deficiency results in an increase in baseline
locomotor activity
We next aimed to investigate the behavioural conse-
quences of CXCR5 deficiency. A useful initial test is the
open field test which provides information on baseline
locomotor activity which may be a significant confounder
for further behavioural testing [29]. In our study we found
that CXCR5 deficiency was associated with a two-fold in-
crease in baseline locomotor activity as assessed by dis-
tance travelled during the test (21.9 ± 0.6 vs. 13.0 ± 0.9;
n = 11 per group; P <0.0001) (Figure 4). We also found
Figure 3 No effect of CXCR5−/− on hippocampal IBA-1 staining. (A) No difference in hippocampal microglia between CXCR5−/− and WT
control animals (P >0.05; n = 6 per group). (B) No difference in percentage of activated hippocampal microglia between CXCR5−/− and WT
animals (P >0.05; n = 6 per group). (C, D) IBA-1 stained WT/CXCR5−/− dentate gyrus representative images, respectively.
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open field by CXCR5 deficient animals which may be
interpreted as a reduction in stress responsiveness (55.9 ±
6.2 vs. 34.1 ± 5.4; n = 11 per group; P = 0.015), however such
an interpretation should be regarded with caution given
the overall increase in locomotor activity (Figure 4A, B). In
view of the result on locomotor activity which would
make it difficult to interpret the results of conventionalFigure 4 CXCR5−/− is associated with increased baseline locomotor acti
behaviour. (A) CXCR5−/− is associated with increased locomotor activity over
n = 11 per group). (B) CXCR5−/− is associated with increased time spent in the
(* P = 0.015; n = 11 per group). (C) No difference in saccharin preference betwhippocampus-dependent learning and memory tasks
(for example, Barnes Maze or Morris Water Maze [30]),
we have pursued behavioural testing which did not require
locomotor activity.
CXCR5 deficiency does not alter anhedonia-like behaviour
Although the mechanistic relevance of hippocampal neuro-
genesis to depression or depression-like behaviours remainsvity and decreased anxiety-like behaviour but not anhedonia-like
5 min in the open field test as compared to WT controls (* P <0.0001;
inner zone of the open field test as compared to WT controls
een CXCR5−/− and WT animals (P = 0.098; n = 11 per group).
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stress and/or depression-like behaviour these behaviours
are correlated with impairments in neurogenesis, and
certain antidepressant medications are associated with
increases in neurogenesis [5]. We therefore investigated
the effects of CXCR5 deficiency on the saccharin prefer-
ence test which is a well established model of anhedonia-
like behaviour and does not require locomotor activity
[31]. All animals consistently demonstrated a preference
for the saccharin-sweetened solution during training
(data not shown), however during testing there was no
significant effect of CXCR5 deficiency on saccharin
preference as compared to WT controls (72.6 ± 3.5 vs.
80.65 ± 3.0; n = 11 per group; P = 0.1) (Figure 4C).
Interestingly, these data suggest a non-significant trend
toward an anhedonia-like phenotype of CXCR5 defi-
cient mice - the opposite of what would be expected if
depression-like behaviours were associated with impaired
neurogenesis.
Discussion
This is the first study to suggest that CXCR5 may impair
the maintenance of hippocampal neuroblast and neur-
onal precursor cell populations, while increasing the
proliferation of (Ki67 positive) cells in the subgranular
zone of the dentage gyrus, however the mechanism for
this and the consequences for learning and memory
function remain uncertain. This result, obtained in mice
is somewhat in contrast to recent results suggestive of
a role of CXCR5 in supporting proliferation of imma-
ture neuronal cells in zebrafish [20]. There are several
possible explanations for these results. Perhaps the
most likely is that CXCR5 may exert a detrimental effect
on the hippocampal neuroblast precursor cell popula-
tions - perhaps through an inflammatory or pro-apoptotic
mechanism. While our preliminary investigations here
have not found any gross alteration in CNS specific or
systemic immune function, we cannot exclude such an
effect. The alternative possibility that CXCR5 may affect
the differentiation of these cells also cannot be excluded
with our data. Future studies such as in-vitro addition of
recombinant CXCL13 to neurosphere cultures may shed
further light on this possibility.
The behavioural significance of these neurobiological
differences also remains to be elucidated. Although we
noted an increase in immature cells of a neuronal line-
age, CXCR5 deficiency did not significantly influence
anhedonia-like behaviour. In the presence of a difference in
DCX staining, it may be expected that these mice would
demonstrate differences in hippocampus dependent
learning and memory tasks - however we were unable
to assess this on commonly used behavioural tests
given the confounding effects of the increased baseline
locomotor activity of the transgenic animals. In thissituation it may be relevant to apply novel behavioural
testing strategies which are not reliant on locomotor
activity such as mouse touchscreen tasks analogous to
components of widely used human batteries (for example,
Cambridge Neuropsychological Test Automated Battery
(CANTAB)) [32].
This early result should trigger further investigation of
the neurobiological roles of this chemokine. Several lines
of investigation may provide further useful insight. First,
our study has considered relatively young (<3-month-old)
mice under basal conditions where no stimulus to increase
the demand for neurogenesis has been applied. If CXCR5
is involved in apoptotic processes or the differentiation of
cells to a neuronal lineage application of pro-apoptotic or
pro-neurogenic stimulus may assist to differentiate these
effects. Many options of pro-neurogenic stimulus are
available in a spectrum from exercise to the robust
stimulation associated with seizure models [13,21,33].
Conversely, pro-apoptotic or anti-neurogenic stimulus
may include the analysis of aged mice (for example,
9 months of age) or the application of environmental
stressors such as a chronic unpredictable mild stress
paradigm [4,23]. Finally, further investigation of the
mechanisms by which CXCR5 modulates the prolifera-
tion of subgranular zone cells may assist to elucidate
the role of this chemokine in the complex interrelated
mechanisms which collectively regulate the activity of
NSC/NPCs. These investigations should seek to clarify
whether the influence of CXCR5 is via direct effects of
this receptor as expressed on NPCs or whether it is via
indirect effects of the receptor expressed on other CNS
resident cells including microglia [18,19]. This may be
clarified by the addition of the recombinant ligand for
this receptor (CXCL13) to neurosphere cultures which
have been selectively depleted for other cell types follow-
ing established protocols [13]. Furthermore, the measure-
ment of other soluble factors in brain tissue including
cytokines and neurotrophic factors may provide more
comprehensive insight into the effects of this knockout on
the local hippocampal milieu.
In a broader context the investigation of novel mecha-
nisms which may regulate the activity of NSC/NPCs may
provide insight into not only the physiology of normal
hippocampal function, but also the pathophysiology of
depressive disorders, anxiety disorders and disorders of
cognitive function [5,34]. Chemokines have a particularly
strong rationale for further investigation as mediators of
NSC/NPC activity as many members of this class have
been found to be differentially expressed in clinical studies
of patients with the aforementioned disorders [35,36].
With further translational development chemokines and
receptors may prove to be clinically relevant targets for
novel diagnostic or therapeutic strategies in the manage-
ment of these disorders.
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This is the first study to demonstrate a role for CXCR5 in
mammalian hippocampal neurobiology. CXCR5 reduces
maintenance of immature neural cell populations and
enhances proliferation of subgranular zone cells in the
hippocampal dentate gyrus, however the mechanism of
these effects remains unclear. Further research will be
required to independently replicate these findings and
further investigate both the mechanisms of this effect
and its cognitive-behavioural correlates. Such investiga-
tions should include a TUNEL assay, BrdU uptake staining
and in-vitro differentiation assays. Further elucidation of
the role of CXCR5 as a regulator of hippocampal neuro-
genesis may provide novel insights into the CNS specific
functions of chemokines and stimulate further investiga-
tion of this relatively neglected family of immune proteins.
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